A case is described of acute respiratory failure secondary to variable intrathoracic large airway obstruction due to a lung neoplasm. Successful ventilation was achieved with facemask bilevel non-invasive ventilatory assistance allowing radiotherapy and chemotherapy to be undertaken.
Non-invasive positive pressure ventilation (NPPV) in acute respiratory failure has been shown in four published prospective randomized trials to be an effective therapeutic modality in acute exacerbations of chronic obstructive airway disease and in hypercapnic acute respiratory failure [1] [2] [3] [4] . There are only a limited number of case reports of NPPV in the treatment of acute respiratory failure caused by bronchogenic carcinoma 5, 6 . We report a case of acute hypercapnic respiratory failure secondary to malignant tracheobronchial obstruction managed by facemask bilevel non-invasive ventilatory assistance.
CASE HISTORY
A 48-year-old male presented with a two-year history of exertional dyspnoea with recent progression over a two-month period. This was associated with a nonproductive cough, inspiratory stridor, dysphagia and weight loss. He was a 60 pack-year smoker. Respiratory function tests indicated a mixed obstructive/restrictive pattern with an FEV 1 /FVC=1.06/2.40 litres (predicted=3.38/4.14). Static computerized tomography in full inspiration showed massive mediastinal lymphadenopathy with extrinsic compression causing obstruction of the distal trachea to a diameter of 13 mm. There was marked compression of the right main bronchus to 6.7 mm diameter and the left main bronchus to 5 mm diameter.
Bronchoscopy showed extrinsic compression of the distal trachea and the right main bronchus. The left main bronchus was narrowed by mucosal infiltration extending to the carina. The trachea and major bronchi showed dynamic collapse in expiration with only a 5 mm bronchoscope able to be passed during inspiration. There was no vocal cord dysfunction. Biopsy of the tumour was reported as a mixed small and large cell bronchogenic carcinoma.
The patient was re-admitted with acute respiratory failure 10 days following his original presentation whilst awaiting outpatient radiotherapy and chemotherapy.
On initial examination the patient was in acute respiratory distress with marked inspiratory stridor, palpable inspiratory and expiratory monophonic wheeze over the right mid-zone and an audible high-pitched expiratory decrescendo wheeze over the left lung. Arterial blood gases (ABGs) on an inspired oxygen (FiO 2 ) of 0.5 were pH 7.35, PaO 2 77 mmHg, P a CO 2 53 mmHg, HCO 3 28 mmol/l. Chest X-ray showed hyperinflated lungs fields, a widened mediastinum and right middle lobe collapse. Initial management included oxygen at litres/min by facemask, intravenous dexamethasone 4 mg, nebulized salbutamol 5 mg and ipratropium bromide 250 mg. This resulted in some improvement and resolution of the stridor.
Radiotherapy was commenced. The first fraction of 40 Gy was given within five hours of admission. Increasing respiratory distress developed two hours following radiotherapy. There was return of the inspiratory stridor, decreased breath sounds in the left lung and arterial oxygen desaturation ( Figure 1 ). Initiation of helium/oxygen mixture (70:30) by facemask and nebulized bronchodilator were without clinical effect. The patient was commenced on facemask NPPV (BiPAP Vision Ventilatory Support System, Respironics Inc, Murrayville, U.S.A.). Initially, a continuous positive airway pressure (CPAP) of 5 cmH 2 O and an FiO 2 of 0.5 was commenced with an inspiratory positive airway pressure of 10 cmH 2 O added for inspiratory support in spontaneous/timed mode. The parameters were adjusted according to clinical response to an FiO 2 of 0.4, inspiratory pressure (IPAP) of 20 cmH 2 0 and an endexpiratory pressure (EPAP) of 5 cmH 2 O with an I:E ratio of 1:3. A rate of four breaths per minute was selected to provide some ventilation in the event of apnoea. In general, ventilatory support was spontaneously triggered. Methylprednisolone 1.0 g intravenously was also given. There was an improvement in oxygen saturation, respiratory rate and subjective reported dyspnoea within 15 minutes of commencing ventilatory support. Within one hour of initiation of NPPV, the ABGs on an FiO 2 0.4 were a pH 7.36, PO 2 88 mmHg, PCO 2 44 mmHg, HCO 3 24 mmol/l.
Chemotherapy with carboplatin and etopiside was commenced. Radiotherapy was discontinued as it was thought to have contributed to tumour swelling, thus increasing the large airway obstruction. Within 39 hours the patient was weaned from NPPV. Radiotherapy was recommenced and chemotherapy continued without further respiratory difficulties.
DISCUSSION
Non-invasive positive pressure ventilation has been used for many causes of acute respiratory failure including chronic obstructive airways disease, asthma, acute pulmonary oedema, pneumonia, restrictive lung disease, pulmonary embolism, acute respiratory distress syndrome, cystic fibrosis and postoperative respiratory failure [1] [2] [3] [4] [5] [6] [7] . Only a limited number of cases of bronchogenic carcinoma complicated by acute respiratory failure are reported in the literature. Meduri and colleagues reported two patients with acute respiratory failure complicating lung cancer 5 . Pneumonia and an exacerbation of chronic obstructive airway disease were responsible for the respiratory failure in these patients. In our case, bilevel non-invasive ventilatory assistance was used to relieve variable intrathoracic large airway obstruction secondary to extrinsic compression and mucosal infiltration by lung tumour. This has not been previously reported.
Bronchogenic carcinoma presenting in acute respiratory failure due to tracheobronchial obstruction in a young male is unusual. Management with corticosteroids and supplementary oxygen is usually effective. Endotracheal intubation and mechanical ventilation followed by bronchoscopy and stenting may be 8 . In an older age group, palliative care may have been appropriate. In view of our patient's age, the potentially reversible nature of the respiratory failure and the absence of previous treatment for his malignancy, NPPV was chosen to provide ventilatory support during chemotherapy and radiotherapy.
The application of positive airway pressure was clinically effective in splinting the expiratory dynamic collapse of the large intrathoracic airways. This clinical improvement may have been due to the positive end-expiratory pressure in which case CPAP alone would be an effective modality. The ventilatory assistance provided by bilevel noninvasive ventilation has been associated with a decrease in the workload of the respiratory muscles and improved alveolar ventilation in patients with chronic obstructive airways disease 9 . The improvement in gas exchange and symptoms within one hour of initiation of facemask bilevel non-invasive ventilatory assistance are consistent with reported results of non-invasive positive pressure ventilation 14,5 . The bilevel non-invasive ventilatory settings are similar to those previously reported for facemask ventilation 10, 11 .
NPPV conferred specific advantages in the management of this case. NPPV leaves the airway defence mechanism intact 7 . This reduces the risk of nosocomial pneumonia especially in a patient undergoing chemotherapy. Endotracheal intubation and stenting is commonly employed in this clinical setting. A secure airway is obtained with endotracheal intubation, protecting against progressive airway swelling from radiotherapy. Non-invasive ventilation techniques have been used successfully in the management of COPD with timely conversion to invasive ventilation when required. The use of facemask ventilation avoided the risk of upper airways trauma, aspiration during intubation and long-term complications such as tracheal stenosis. Communication and physical interaction can be continued since there is minimal sedation and the speech mechanism is left intact 5 . Oral nutrition is also possible. The ease of application has the advantage of allowing earlier intervention and discontinuation of ventilation. The extent of large airways involvement in this patient would have made stenting technically difficult.
No major complications were encounted during NPPV ventilation. There was some facemask discomfort and air leakage causing eye irritation. However, no facial skin necrosis occurred which is a reported complication in 10% of patients 7 . This may occur early with a poorly fitting mask. This modality of support has the potential risk of aspiration secondary to chemotherapy-and radiotherapy-induced emesis.
NPPV-induced aerophagia and gastric distension may contribute to this risk. Only alert, cooperative, haemodynamically stable patients can safely undertake NPPV support. Furthermore, patient intolerance may occur in 10 to 23% of patients 16, 12 . Lack of familiarity by the staff with NPPV ventilation may also limit its application.
Bilevel non-invasive ventilatory assistance for dynamic large airways obstruction associated with bronchogenic carcinoma is a safe alternative to invasive support whilst definitive therapy is implemented. This case represents a new application of bilevel noninvasive ventilatory assistance in a patient with a potentially reversible cause of acute hypercapnic respiratory failure.
